/
Stock
/
/
APIChangelogInfo

ROCKET PHARMACEUTICALS

Trade RCKT
RCKT Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-05-20
2025-05-22
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-357
$6.00
-2,142
1
$310.29M
2025-05-20
2025-05-22
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-587
$6.00
-3,522
1
$310.29M
2025-05-20
2025-05-22
SHAH GAURAV
CEO
S - Sale
Common Stock
-2,253
$6.00
-13,518
1
$310.29M
2025-05-20
2025-05-22
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-801
$6.00
-4,806
1
$310.29M
2025-05-20
2025-05-22
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-767
$6.00
-4,602
1
$310.29M
2025-05-16
2025-05-20
SHAH GAURAV
CEO
S - Sale
Common Stock
-3,621
$7.00
-25,347
1
$310.29M
2025-05-16
2025-05-20
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-655
$7.00
-4,585
1
$310.29M
2025-05-16
2025-05-20
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-1,409
$7.00
-9,863
1
$310.29M
2025-05-16
2025-05-20
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-1,582
$7.00
-11,074
1
$310.29M
2025-05-16
2025-05-20
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-946
$7.00
-6,622
1
$310.29M
2025-04-22
2025-04-24
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-718
$7.00
-5,026
1
$310.29M
2025-03-05
2025-04-24
DOLSTEN MIKAEL
J - Other
Common Stock
14,220
$0.00
1
$310.29M
2025-04-10
2025-04-14
SHAH GAURAV
CEO
P - Purchase
Common Stock
20,000
$5.00
100K
1
$310.29M
2025-04-09
2025-04-10
PATEL KINNARI
President, Head of R&D and Chi...
P - Purchase
Common Stock
21,099
$5.00
105K
1
$310.29M
2025-04-09
2025-04-09
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
-3,382
$5.00
-16,910
1
$310.29M
2025-04-04
2025-04-08
ONDREY AARON
Chief Financial Officer
S - Sale
Common Stock
-7,489
$5.00
-37,445
1
$310.29M
2025-02-25
2025-02-27
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-6,532
$11.00
-71,852
1
$310.29M
2024-11-21
2025-02-27
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-3,097
$13.00
-40,261
1
$310.29M
2024-08-16
2025-02-27
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-2,710
$19.00
-51,490
1
$310.29M
2024-05-17
2025-02-27
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
S - Sale
Common Stock
-2,754
$23.00
-63,342
1
$310.29M
2025-02-21
2025-02-25
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-6,078
$11.00
-66,858
1
$310.29M
2025-02-21
2025-02-25
SHAH GAURAV
CEO
S - Sale
Common Stock
-16,303
$11.00
-179K
1
$310.29M
2025-02-21
2025-02-25
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-3,222
$11.00
-35,442
1
$310.29M
2025-02-21
2025-02-25
SHAH GAURAV
CEO
S - Sale
Common Stock
-16,303
$11.00
-179K
1
$310.29M
2025-02-21
2025-02-25
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-2,737
$11.00
-30,107
1
$310.29M
2025-02-21
2025-02-25
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-6,078
$11.00
-66,858
1
$310.29M
2025-02-21
2025-02-25
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-3,222
$11.00
-35,442
1
$310.29M
2025-02-21
2025-02-25
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-2,737
$11.00
-30,107
1
$310.29M
2025-02-21
2025-02-21
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
-1,222
$11.00
-13,442
1
$310.29M
2025-02-11
2025-02-13
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
243K
$0.00
1
$310.29M
2025-02-11
2025-02-13
MILITELLO JOHN
Vice President of Finance, Tre...
A - Grant
Stock Option (Right to Buy)
29,920
$0.00
1
$310.29M
2025-02-11
2025-02-13
MILITELLO JOHN
Vice President of Finance, Tre...
A - Grant
Common Stock
20,080
$0.00
1
$310.29M
2025-02-11
2025-02-13
MILITELLO JOHN
Vice President of Finance, Tre...
A - Grant
Stock Option (Right to Buy)
29,920
$0.00
1
$310.29M
2025-02-11
2025-02-13
MILITELLO JOHN
Vice President of Finance, Tre...
A - Grant
Common Stock
20,080
$0.00
1
$310.29M
2025-02-11
2025-02-13
ONDREY AARON
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$310.29M
2025-02-11
2025-02-13
ONDREY AARON
Chief Financial Officer
A - Grant
Common Stock
90,358
$0.00
1
$310.29M
2025-02-11
2025-02-13
PATEL KINNARI
President, Head of R&D and Chi...
A - Grant
Stock Option (Right to Buy)
172K
$0.00
1
$310.29M
2025-02-11
2025-02-13
PATEL KINNARI
President, Head of R&D and Chi...
A - Grant
Common Stock
57,786
$0.00
1
$310.29M
2025-02-11
2025-02-13
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$310.29M
2025-02-11
2025-02-13
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
A - Grant
Common Stock
80,318
$0.00
1
$310.29M
2025-02-11
2025-02-13
SHAH GAURAV
CEO
A - Grant
Common Stock
81,655
$0.00
1
$310.29M
2025-02-11
2025-02-13
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$310.29M
2025-02-11
2025-02-13
WILSON MARTIN
General Counsel
A - Grant
Common Stock
90,358
$0.00
1
$310.29M
2025-02-11
2025-02-13
ONDREY AARON
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$310.29M
2025-02-11
2025-02-13
ONDREY AARON
Chief Financial Officer
A - Grant
Common Stock
90,358
$0.00
1
$310.29M
2025-02-11
2025-02-13
PATEL KINNARI
President, Head of R&D and Chi...
A - Grant
Stock Option (Right to Buy)
172K
$0.00
1
$310.29M
2025-02-11
2025-02-13
PATEL KINNARI
President, Head of R&D and Chi...
A - Grant
Common Stock
57,786
$0.00
1
$310.29M
2025-02-11
2025-02-13
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$310.29M
2025-02-11
2025-02-13
SCHWARTZ JONATHAN DAVID
Chief Medical & Gene Therapy O...
A - Grant
Common Stock
80,318
$0.00
1
$310.29M
2025-02-11
2025-02-13
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
243K
$0.00
1
$310.29M
2025-02-11
2025-02-13
SHAH GAURAV
CEO
A - Grant
Common Stock
81,655
$0.00
1
$310.29M
2025-02-11
2025-02-13
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
135K
$0.00
1
$310.29M
2025-02-11
2025-02-13
WILSON MARTIN
General Counsel
A - Grant
Common Stock
90,358
$0.00
1
$310.29M
2025-02-03
2025-02-05
PRATUMSUWAN PIRATIP
A - Grant
Stock Option (Right to Buy)
73,624
$0.00
2
$310.29M
2025-01-31
2025-01-31
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
-2,824
$11.00
-31,064
1
$310.29M
2025-01-23
2025-01-27
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-896
$10.00
-8,960
1
$310.29M
2024-12-12
2024-12-16
RTW INVESTMENTS, LP
A - Grant
Pre-funded Warrant (right to buy)
400K
$12.00
4.80M
1
$310.29M
2024-11-21
2024-11-25
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-1,224
$13.00
-15,912
1
$310.29M
2024-11-21
2024-11-25
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-4,588
$13.00
-59,644
1
$310.29M
2024-11-21
2024-11-25
SHAH GAURAV
CEO
S - Sale
Common Stock
-11,091
$13.00
-144K
1
$310.29M
2024-11-21
2024-11-25
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-1,175
$13.00
-15,275
1
$310.29M
2024-10-31
2024-11-04
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-917
$17.00
-15,589
1
$310.29M
2024-10-31
2024-11-04
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
Common Stock
-3,080
$17.00
-52,360
1
$310.29M
2024-09-26
2024-10-29
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
607
$0.00
1
$310.29M
2024-09-26
2024-10-29
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
507
$0.00
2
$310.29M
2024-09-09
2024-09-11
DOLSTEN MIKAEL
A - Grant
Stock Option (Right to Buy)
50,533
$0.00
2
$310.29M
2024-08-16
2024-08-20
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-1,064
$19.00
-20,216
1
$310.29M
2024-08-16
2024-08-20
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-3,989
$19.00
-75,791
1
$310.29M
2024-08-16
2024-08-20
SHAH GAURAV
CEO
S - Sale
Common Stock
-9,650
$19.00
-183K
1
$310.29M
2024-08-16
2024-08-20
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-1,027
$19.00
-19,513
1
$310.29M
2024-07-22
2024-07-24
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-812
$23.00
-18,676
1
$310.29M
2024-07-08
2024-07-09
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
Common Stock
-3,026
$20.00
-60,520
1
$310.29M
2024-06-13
2024-06-20
GRANADILLO PEDRO
A - Grant
Stock Option (Right to Buy)
28,599
$2.00
57,198
2
$310.29M
2024-06-13
2024-06-20
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
26,604
$2.00
53,208
2
$310.29M
2024-06-13
2024-06-20
MALIK FADY IBRAHAM
A - Grant
Stock Option (Right to Buy)
23,944
$0.00
1
$310.29M
2024-06-13
2024-06-20
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
27,269
$2.00
54,538
2
$310.29M
2024-06-13
2024-06-20
BOESS CARSTEN
A - Grant
Stock Option (Right to Buy)
23,944
$0.00
1
$310.29M
2024-06-13
2024-06-20
SOUTHWELL DAVID
A - Grant
Stock Option (Right to Buy)
23,944
$0.00
1
$310.29M
2024-06-13
2024-06-20
WONG RODERICK
A - Grant
Stock Option (Right to Buy)
27,269
$2.00
54,538
2
$310.29M
2024-06-13
2024-06-20
WOODS KEITH
A - Grant
Stock Option (Right to Buy)
23,944
$0.00
1
$310.29M
2024-06-13
2024-06-20
YALAMANCHI NAVEEN
A - Grant
Stock Option (Right to Buy)
23,944
$0.00
1
$310.29M
2024-03-21
2024-06-10
MAKKER GOTHAM
S - Sale
Common Stock
-274K
$28.00
-7.67M
1
$310.29M
2024-05-16
2024-05-20
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-1,079
$23.00
-24,817
1
$310.29M
2024-05-16
2024-05-20
SHAH GAURAV
CEO
S - Sale
Common Stock
-9,790
$23.00
-225K
1
$310.29M
2024-05-16
2024-05-20
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-1,048
$23.00
-24,104
1
$310.29M
2024-05-16
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
Common Stock
-4,046
$23.00
-93,058
1
$310.29M
2024-05-14
2024-05-20
SHAH GAURAV
CEO
M - Exercise
Common Stock
17,662
$0.00
2
$310.29M
2024-05-14
2024-05-20
WILSON MARTIN
General Counsel
M - Exercise
Restricted Stock Units
-2,420
$0.00
1
$310.29M
2024-05-14
2024-05-20
WILSON MARTIN
General Counsel
M - Exercise
Common Stock
2,420
$0.00
1
$310.29M
2024-05-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
M - Exercise
Restricted Stock Units
-9,523
$0.00
2
$310.29M
2024-05-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
M - Exercise
Common Stock
9,543
$0.00
2
$310.29M
2024-05-14
2024-05-20
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
-17,662
$0.00
2
$310.29M
2024-05-02
2024-05-20
SOUTHWELL DAVID
G - Gift
Common Stock
-173K
$0.00
2
$310.29M
2023-02-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Restricted Stock Units
-38,735
$0.00
1
$310.29M
2023-02-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Common Stock [F2,F3]
38,735
$0.00
1
$310.29M
2023-02-14
2024-05-20
SHAH GAURAV
CEO
J - Other
Common Stock [F2,F3]
67,785
$0.00
1
$310.29M
2023-02-14
2024-05-20
WILSON MARTIN
General Counsel
J - Other
Restricted Stock Units [F1,F2]
-16,947
$0.00
1
$310.29M
2023-02-14
2024-05-20
WILSON MARTIN
General Counsel
J - Other
Common Stock [F1,F2]
16,947
$0.00
1
$310.29M
2023-02-14
2024-05-20
SHAH GAURAV
CEO
J - Other
Restricted Stock Units
-67,785
$0.00
1
$310.29M
2022-08-12
2024-05-20
WILSON MARTIN
General Counsel
J - Other
Common Stock [F2,F3]
28,763
$0.00
1
$310.29M
2022-08-12
2024-05-20
WILSON MARTIN
General Counsel
J - Other
Restricted Stock Units [F2,F3]
-28,763
$0.00
1
$310.29M
2022-08-12
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Common Stock [F3,F4]
52,489
$0.00
1
$310.29M
2022-08-12
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Restricted Stock Units
-52,489
$0.00
1
$310.29M
2022-02-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Restricted Stock Units
-11,970
$0.00
1
$310.29M
2022-02-14
2024-05-20
PATEL KINNARI
President, Head of R&D and Chi...
J - Other
Common Stock [F1,F3]
11,970
$0.00
1
$310.29M
2022-02-14
2024-05-20
SHAH GAURAV
CEO
J - Other
Restricted Stock Units
-23,940
$0.00
1
$310.29M
2022-02-14
2024-05-20
SHAH GAURAV
CEO
J - Other
Common Stock [F1,F3]
23,940
$0.00
1
$310.29M
2024-04-22
2024-04-24
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
Common Stock
-833
$23.00
-19,159
1
$310.29M
2024-04-15
2024-04-16
SOUTHWELL DAVID
M - Exercise
Common Stock
29,624
$4.00
118K
1
$310.29M
2024-04-15
2024-04-16
SOUTHWELL DAVID
M - Exercise
Stock Option (Right to Buy)
-29,624
$4.00
-118K
1
$310.29M
2024-04-15
2024-04-16
SOUTHWELL DAVID
S - Sale
Common Stock
-10,000
$24.00
-240K
1
$310.29M
2024-04-12
2024-04-16
SOUTHWELL DAVID
M - Exercise
Stock Option (Right to Buy)
-70,000
$4.00
-280K
1
$310.29M
2024-04-12
2024-04-16
SOUTHWELL DAVID
M - Exercise
Common Stock
70,000
$4.00
280K
1
$310.29M
2024-04-12
2024-04-16
SOUTHWELL DAVID
S - Sale
Common Stock
-70,000
$24.00
-1.68M
2
$310.29M
2024-04-08
2024-04-10
WHITE MARK ANDREW
General Manager, Commercial Af...
S - Sale
Common Stock
-12,532
$25.00
-313K
1
$310.29M
2024-04-01
2024-04-03
ONDREY AARON
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
69,337
$0.00
1
$310.29M
2024-04-01
2024-04-03
ONDREY AARON
Chief Financial Officer
A - Grant
Common Stock
46,781
$0.00
1
$310.29M
2024-03-21
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-2,490
$28.00
-69,720
1
$310.29M
2024-03-21
2024-03-25
MAKKER GOTHAM
S - Sale
Common Stock
-274K
$28.00
-7.67M
1
$310.29M
2023-02-14
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Restricted Stock Units [F1,F2]
11,067
$0.00
1
$310.29M
2023-02-14
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Common Stock [F1,F2]
11,067
$0.00
1
$310.29M
2022-08-12
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Common Stock [F1,F3]
14,310
$0.00
1
$310.29M
2022-08-12
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Restricted Stock Units [F1,F3]
14,310
$0.00
1
$310.29M
2022-04-18
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Common Stock [F1,F2]
7,932
$0.00
1
$310.29M
2022-04-18
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Restricted Stock Units [F1,F2]
7,932
$0.00
1
$310.29M
2022-02-14
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Common Stock [F1,F2]
2,903
$0.00
1
$310.29M
2022-02-14
2024-03-25
MILITELLO JOHN
VP, Principal Accounting Offic...
J - Other
Restricted Stock Units [F1,F2]
2,903
$0.00
1
$310.29M
2024-02-29
2024-03-04
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Stock Option (Right to Buy)
-10,000
$13.00
-130K
1
$310.29M
2024-02-29
2024-03-04
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
10,000
$13.00
130K
1
$310.29M
2024-02-29
2024-03-04
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-10,000
$30.00
-300K
1
$310.29M
2024-02-29
2024-03-04
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-4,100
$29.00
-119K
1
$310.29M
2024-02-16
2024-02-21
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Common Stock [F1,F4]
8,322
$0.00
1
$310.29M
2024-02-16
2024-02-21
WILSON MARTIN
General Counsel
S - Sale
Common Stock
-3,576
$30.00
-107K
1
$310.29M
2024-02-16
2024-02-21
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Stock Option (Right to Buy)
24,545
$0.00
1
$310.29M
2024-02-16
2024-02-21
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Stock Option (Right to Buy)
98,183
$0.00
1
$310.29M
2024-02-16
2024-02-21
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Common Stock [F1,F4]
33,288
$0.00
1
$310.29M
2024-02-16
2024-02-21
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
196K
$0.00
1
$310.29M
2024-02-16
2024-02-21
SHAH GAURAV
CEO
A - Grant
Common Stock [F1,F4]
66,577
$0.00
1
$310.29M
2024-02-16
2024-02-21
WHITE MARK ANDREW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
32,727
$0.00
1
$310.29M
2024-02-16
2024-02-21
WHITE MARK ANDREW
Chief Medical Officer
A - Grant
Common Stock
11,096
$0.00
1
$310.29M
2024-02-16
2024-02-21
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
49,091
$0.00
1
$310.29M
2024-02-16
2024-02-21
WILSON MARTIN
General Counsel
A - Grant
Common Stock [F1,F4]
16,644
$0.00
1
$310.29M
2024-02-16
2024-02-21
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-3,238
$30.00
-97,140
1
$310.29M
2024-02-16
2024-02-21
PATEL KINNARI
President & Chief Operating Of...
S - Sale
Common Stock
-7,132
$30.00
-214K
1
$310.29M
2024-02-16
2024-02-21
SHAH GAURAV
CEO
S - Sale
Common Stock
-20,272
$30.00
-608K
1
$310.29M
2024-02-14
2024-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-6,274
$0.00
2
$310.29M
2024-02-14
2024-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
6,274
$0.00
1
$310.29M
2024-02-14
2024-02-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
-26,189
$0.00
2
$310.29M
2024-02-14
2024-02-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
26,189
$0.00
1
$310.29M
2024-02-14
2024-02-16
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
-46,828
$0.00
2
$310.29M
2024-02-14
2024-02-16
SHAH GAURAV
CEO
M - Exercise
Common Stock
-46,828
$0.00
1
$310.29M
2024-02-14
2024-02-16
WILSON MARTIN
General Counsel
M - Exercise
Restricted Stock Units
-9,712
$0.00
1
$310.29M
2024-02-14
2024-02-16
WILSON MARTIN
General Counsel
M - Exercise
Common Stock
-9,712
$0.00
1
$310.29M
2024-01-22
2024-01-23
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-638
$27.00
-17,226
1
$310.29M
2024-01-18
2024-01-22
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-1,586
$0.00
1
$310.29M
2024-01-18
2024-01-22
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
1,586
$0.00
1
$310.29M
2023-12-07
2023-12-12
WOODS KEITH
A - Grant
Stock Option (Right to Buy)
32,482
$0.00
2
$310.29M
2023-11-16
2023-11-16
SHAH GAURAV
CEO
S - Sale
-4,627
$21.00
-97,167
1
$310.29M
2023-11-16
2023-11-16
MILITELLO JOHN
Vice President of Finance, Tre...
S - Sale
-274
$21.00
-5,754
1
$310.29M
2023-11-16
2023-11-16
PATEL KINNARI
President, Head of R&D and Chi...
S - Sale
-1,148
$21.00
-24,108
1
$310.29M
2023-11-15
2023-11-16
MAKKER GOTHAM
S - Sale
Common Stock
-20,000
$23.00
-460K
1
$310.29M
2023-11-14
2023-11-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-725
$0.00
1
$310.29M
2023-11-14
2023-11-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
725
$0.00
1
$310.29M
2023-11-14
2023-11-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
-3,989
$0.00
1
$310.29M
2023-11-14
2023-11-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
3,989
$0.00
1
$310.29M
2023-11-14
2023-11-16
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
-7,979
$0.00
1
$310.29M
2023-11-14
2023-11-16
SHAH GAURAV
CEO
M - Exercise
Common Stock
-7,979
$0.00
1
$310.29M
2023-10-20
2023-10-25
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-564
$17.00
-9,588
1
$310.29M
2023-10-18
2023-10-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-1,586
$0.00
1
$310.29M
2023-10-18
2023-10-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
1,586
$0.00
1
$310.29M
2023-02-17
2023-10-20
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-1,076
$19.00
-20,444
1
$310.29M
2023-10-05
2023-10-10
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
-3,333
$0.00
1
$310.29M
2023-10-05
2023-10-10
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
3,333
$0.00
1
$310.29M
2023-09-29
2023-10-02
MAKKER GOTHAM
S - Sale
Common Stock
-4,677
$21.00
-98,217
1
$310.29M
2023-09-28
2023-10-02
MAKKER GOTHAM
S - Sale
Common Stock
-10,312
$21.00
-217K
1
$310.29M
2023-09-15
2023-09-19
RTW INVESTMENTS, LP
P - Purchase
Pre-funded Warrant (right to buy)
3.13M
$16.00
50M
1
$310.29M
2023-08-28
2023-08-30
RTW INVESTMENTS, LP
J - Other
Equity Swap (obligation to sell)
-1
1
$310.29M
2023-08-28
2023-08-30
RTW INVESTMENTS, LP
J - Other
Equity Swap (obligation to buy)
-1
1
$310.29M
2023-08-28
2023-08-30
RTW INVESTMENTS, LP
J - Other
Common Stock
500K
$16.00
8.00M
1
$310.29M
2023-08-28
2023-08-30
RTW INVESTMENTS, LP
J - Other
Common Stock, $0.01 par value ("Common Stock")
500K
$22.00
11M
1
$310.29M
2023-08-28
2023-08-30
RTW INVESTMENTS, LP
J - Other
Common Stock
-1.00M
$19.00
-19M
2
$310.29M
2023-08-17
2023-08-21
PATEL KINNARI
President & Chief Operating Of...
S - Sale
Common Stock
-1,534
$15.00
-23,010
1
$310.29M
2023-08-17
2023-08-21
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-284
$15.00
-4,260
1
$310.29M
2023-08-17
2023-08-21
SHAH GAURAV
CEO
S - Sale
Common Stock
-4,767
$15.00
-71,505
1
$310.29M
2023-08-14
2023-08-15
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-725
$0.00
1
$310.29M
2023-08-14
2023-08-15
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
725
$0.00
1
$310.29M
2023-08-14
2023-08-15
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
-3,989
$0.00
1
$310.29M
2023-08-14
2023-08-15
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
3,989
$0.00
1
$310.29M
2023-08-14
2023-08-15
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
-7,979
$0.00
1
$310.29M
2023-08-14
2023-08-15
SHAH GAURAV
CEO
M - Exercise
Common Stock
7,979
$0.00
1
$310.29M
2023-07-20
2023-07-24
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-573
$19.00
-10,887
1
$310.29M
2023-07-18
2023-07-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-1,586
$0.00
1
$310.29M
2023-07-18
2023-07-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
1,586
$0.00
1
$310.29M
2023-06-22
2023-06-26
BOESS CARSTEN
A - Grant
Stock Option (Right to Buy)
25,850
$0.00
1
$310.29M
2023-06-22
2023-06-26
GRANADILLO PEDRO
A - Grant
Stock Option (Right to Buy)
30,876
$2.00
61,752
2
$310.29M
2023-06-22
2023-06-26
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
29,440
$2.00
58,880
2
$310.29M
2023-06-22
2023-06-26
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
28,722
$1.00
28,722
2
$310.29M
2023-06-22
2023-06-26
MALIK FADY IBRAHAM
A - Grant
Stock Option (Right to Buy)
25,850
$0.00
1
$310.29M
2023-06-22
2023-06-26
SOUTHWELL DAVID
A - Grant
Stock Option (Right to Buy)
25,850
$0.00
1
$310.29M
2023-06-22
2023-06-26
WONG RODERICK
A - Grant
Stock Option (Right to Buy)
29,440
$2.00
58,880
2
$310.29M
2023-06-22
2023-06-26
YALAMANCHI NAVEEN
A - Grant
Stock Option (Right to Buy)
25,850
$0.00
1
$310.29M
2023-05-17
2023-05-19
PATEL KINNARI
President & Chief Operating Of...
S - Sale
Common Stock
-1,330
$21.00
-27,930
1
$310.29M
2023-05-17
2023-05-19
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-245
$21.00
-5,145
1
$310.29M
2023-05-17
2023-05-19
SHAH GAURAV
CEO
S - Sale
Common Stock
-4,122
$21.00
-86,562
1
$310.29M
2023-05-17
2023-05-17
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
-712
$21.00
-14,952
1
$310.29M
2023-05-14
2023-05-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
725
$0.00
1
$310.29M
2023-05-14
2023-05-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
-3,989
$0.00
1
$310.29M
2023-05-14
2023-05-16
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
3,989
$0.00
1
$310.29M
2023-05-14
2023-05-16
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
-7,979
$0.00
1
$310.29M
2023-05-14
2023-05-16
SHAH GAURAV
CEO
M - Exercise
Common Stock
7,979
$0.00
1
$310.29M
2023-05-14
2023-05-16
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
-725
$0.00
1
$310.29M
2023-04-21
2023-04-25
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-2,342
$19.00
-44,498
1
$310.29M
2023-04-18
2023-04-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
6,364
$0.00
1
$310.29M
2023-04-18
2023-04-20
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
6,364
$0.00
1
$310.29M
2023-04-13
2023-04-13
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
-10,880
$18.00
-196K
1
$310.29M
2023-04-04
2023-04-12
WHITE MARK ANDREW
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
57,739
$0.00
1
$310.29M
2023-04-04
2023-04-12
WHITE MARK ANDREW
Chief Medical Officer
A - Grant
Common Stock, par value $0.01
76,662
$0.00
1
$310.29M
2023-04-11
2023-04-11
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
-4,643
$17.00
-78,931
1
$310.29M
2023-04-06
2023-04-06
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
-12,390
$17.00
-211K
1
$310.29M
2022-12-01
2023-04-05
RTW INVESTMENTS, LP
J - Other
Warrants
61,705
1
$310.29M
2022-12-01
2023-04-05
RTW INVESTMENTS, LP
J - Other
Common stock, $0.01 par value ("Common Stock")
529K
1
$310.29M
2022-05-19
2023-04-05
RTW INVESTMENTS, LP
J - Other
Equity Swap (obligation to buy)
1
1
$310.29M
2023-03-31
2023-03-31
SHAH GAURAV
CEO
S - Sale
-1,611
$19.00
-30,609
1
$310.29M
2023-02-17
2023-02-22
MILITELLO JOHN
VP, Principal Accounting Offic...
S - Sale
Common Stock
-1,244
$19.00
-23,636
1
$310.29M
2023-02-17
2023-02-22
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
Common Stock
-3,557
$19.00
-67,583
1
$310.29M
2023-02-17
2023-02-22
SHAH GAURAV
CEO
S - Sale
Common Stock
-12,194
$19.00
-232K
1
$310.29M
2023-02-14
2023-02-22
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Restricted Stock Units
16,616
$0.00
1
$310.29M
2023-02-14
2023-02-22
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Stock Option (Right to Buy)
49,798
$0.00
1
$310.29M
2023-02-14
2023-02-22
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Restricted Stock Units
66,467
$0.00
1
$310.29M
2023-02-14
2023-02-22
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Stock Option (Right to Buy)
199K
$0.00
1
$310.29M
2023-02-14
2023-02-22
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Restricted Stock Units
41,541
$0.00
1
$310.29M
2023-02-14
2023-02-22
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Stock Option (Right to Buy)
124K
$0.00
1
$310.29M
2023-02-14
2023-02-22
SHAH GAURAV
CEO
A - Grant
Restricted Stock Units
116K
$0.00
1
$310.29M
2023-02-14
2023-02-22
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
349K
$0.00
1
$310.29M
2023-02-14
2023-02-22
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Restricted Stock Units
2,858
$0.00
1
$310.29M
2023-02-14
2023-02-22
MILITELLO JOHN
VP, Principal Accounting Offic...
M - Exercise
Common Stock
2,858
$0.00
1
$310.29M
2023-02-14
2023-02-22
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Restricted Stock Units
15,720
$0.00
1
$310.29M
2023-02-14
2023-02-22
PATEL KINNARI
President & Chief Operating Of...
M - Exercise
Common Stock
15,720
$0.00
1
$310.29M
2023-02-14
2023-02-22
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
M - Exercise
Restricted Stock Units
8,574
$0.00
1
$310.29M
2023-02-14
2023-02-22
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
M - Exercise
Common Stock
8,574
$0.00
1
$310.29M
2023-02-14
2023-02-22
SHAH GAURAV
CEO
M - Exercise
Restricted Stock Units
31,440
$0.00
1
$310.29M
2023-02-14
2023-02-22
SHAH GAURAV
CEO
M - Exercise
Common Stock
31,440
$0.00
1
$310.29M
2023-02-14
2023-02-16
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Restricted Stock Units
41,541
$0.00
1
$310.29M
2023-02-14
2023-02-16
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Stock Option (Right to Buy)
124K
$0.00
1
$310.29M
2023-02-14
2023-02-16
SHAH GAURAV
CEO
A - Grant
Restricted Stock Units
116K
$0.00
1
$310.29M
2023-02-14
2023-02-16
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
349K
$0.00
1
$310.29M
2023-02-14
2023-02-16
WILSON MARTIN
General Counsel
A - Grant
Restricted Stock Units
29,079
$0.00
1
$310.29M
2023-02-14
2023-02-16
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
87,147
$0.00
1
$310.29M
2023-02-14
2023-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Restricted Stock Units
16,616
$0.00
1
$310.29M
2023-02-14
2023-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Stock Option (Right to Buy)
49,798
$0.00
1
$310.29M
2023-02-14
2023-02-16
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Restricted Stock Units
66,467
$0.00
1
$310.29M
2023-02-14
2023-02-16
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Stock Option (Right to Buy)
199K
$0.00
1
$310.29M
2022-12-23
2022-12-23
RTW INVESTMENTS, LP
J - Other
Notional Derivative Agreements (obligation to buy)
1
1
$310.29M
2022-12-22
2022-12-22
RTW INVESTMENTS, LP
J - Other
Notional Derivative Agreements (obligation to buy)
1
1
$310.29M
2022-10-06
2022-10-11
RTW INVESTMENTS, LP
P - Purchase
Common Stock, $0.01 par value ("Common Stock")
1.36M
$15.00
20M
1
$310.29M
2022-08-12
2022-08-16
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Restricted Stock Units
14,310
$0.00
1
$310.29M
2022-08-12
2022-08-16
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Restricted Stock Units
52,489
$0.00
1
$310.29M
2022-08-12
2022-08-16
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Restricted Stock Units
22,896
$0.00
1
$310.29M
2022-08-12
2022-08-16
WILSON MARTIN
General Counsel
A - Grant
Restricted Stock Units
28,763
$0.00
1
$310.29M
2022-08-12
2022-08-16
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
20,318
$0.00
1
$310.29M
2022-06-13
2022-06-15
YALAMANCHI NAVEEN
A - Grant
Stock Option (Right to Buy)
47,745
$0.00
1
$310.29M
2022-06-13
2022-06-15
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
55,090
$1.00
55,090
2
$310.29M
2022-06-13
2022-06-15
BOESS CARSTEN
A - Grant
Stock Option (Right to Buy)
47,745
$0.00
1
$310.29M
2022-06-13
2022-06-15
GRANADILLO PEDRO
A - Grant
Stock Option (Right to Buy)
58,028
$1.00
58,028
2
$310.29M
2022-06-13
2022-06-15
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
53,621
$1.00
53,621
2
$310.29M
2022-06-13
2022-06-15
MALIK FADY IBRAHAM
A - Grant
Stock Option (Right to Buy)
47,745
$0.00
1
$310.29M
2022-06-13
2022-06-15
WONG RODERICK
A - Grant
Stock Option (Right to Buy)
53,621
$1.00
53,621
2
$310.29M
2022-06-13
2022-06-15
SOUTHWELL DAVID
A - Grant
Stock Option (Right to Buy)
47,745
$0.00
1
$310.29M
2022-04-18
2022-04-20
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Restricted Stock Units
19,054
$0.00
1
$310.29M
2022-04-18
2022-04-20
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Stock Option (Right to Buy)
28,910
$0.00
1
$310.29M
2022-04-01
2022-04-04
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
Common Stock
-45,000
$16.00
-720K
2
$310.29M
2022-03-31
2022-04-04
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
Common Stock
-45,000
$16.00
-720K
2
$310.29M
2022-03-30
2022-04-04
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
Common Stock
-45,000
$16.00
-720K
2
$310.29M
2022-03-30
2022-04-01
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
S - Sale
Common Stock
-45,000
$16.00
-720K
2
$310.29M
2022-03-10
2022-03-11
MALIK FADY IBRAHAM
A - Grant
Stock Option (Right to Buy)
41,840
$0.00
2
$310.29M
2021-07-27
2022-03-09
MAKKER GOTHAM
G - Gift
Common Stock
-622K
$0.00
1
$310.29M
2022-02-14
2022-02-16
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Stock Option (Right to Buy)
149K
$0.00
1
$310.29M
2022-02-14
2022-02-16
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Restricted Stock Units
25,984
$0.00
1
$310.29M
2022-02-14
2022-02-16
SCHWARTZ JONATHAN DAVID
Chief Medical Officer & Clinic...
A - Grant
Stock Option (Right to Buy)
81,010
$0.00
1
$310.29M
2022-02-14
2022-02-16
SHAH GAURAV
CEO
A - Grant
Stock Option (Right to Buy)
297K
$0.00
1
$310.29M
2022-02-14
2022-02-16
GARCIA-PARADA CARLOS
Chief Financial Officer
A - Grant
Restricted Stock Units
17,322
$0.00
1
$310.29M
2022-02-14
2022-02-16
GARCIA-PARADA CARLOS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
54,006
$0.00
1
$310.29M
2022-02-14
2022-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Restricted Stock Units
8,661
$0.00
1
$310.29M
2022-02-14
2022-02-16
MILITELLO JOHN
VP, Principal Accounting Offic...
A - Grant
Stock Option (Right to Buy)
27,003
$0.00
1
$310.29M
2022-02-14
2022-02-16
PATEL KINNARI
President & Chief Operating Of...
A - Grant
Restricted Stock Units
47,637
$0.00
1
$310.29M
2022-02-14
2022-02-16
SHAH GAURAV
CEO
A - Grant
Restricted Stock Units
95,275
$0.00
1
$310.29M
2022-02-07
2022-02-08
SHAH GAURAV
CEO
P - Purchase
Common Stock
22,000
$17.00
374K
1
$310.29M
2021-12-06
2021-12-08
WILSON MARTIN
General Counsel
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$310.29M
2021-09-13
2021-09-15
GARCIA-PARADA CARLOS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$310.29M
2021-08-27
2021-08-31
WONG RODERICK
A - Grant
Common Stock
813K
$32.00
26M
1
$310.29M
2021-06-17
2021-06-21
MAKKER GOTHAM
S - Sale
Common Stock
-400
$47.00
-18,800
1
$310.29M
2021-06-16
2021-06-21
MAKKER GOTHAM
S - Sale
Common Stock
-34,685
$47.00
-1.63M
1
$310.29M
2021-06-14
2021-06-16
YALAMANCHI NAVEEN
A - Grant
Stock Option (Right to Buy)
12,236
$0.00
1
$310.29M
2021-06-14
2021-06-16
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
13,935
$4.00
55,740
2
$310.29M
2021-06-14
2021-06-16
BOESS CARSTEN
A - Grant
Stock Option (Right to Buy)
12,236
$0.00
1
$310.29M
2021-06-14
2021-06-16
GRANADILLO PEDRO
A - Grant
Stock Option (Right to Buy)
14,615
$5.00
73,075
2
$310.29M
2021-06-14
2021-06-16
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
13,765
$3.00
41,295
2
$310.29M
2021-06-14
2021-06-16
SOUTHWELL DAVID
A - Grant
Stock Option (Right to Buy)
12,236
$0.00
1
$310.29M
2021-06-14
2021-06-16
WONG RODERICK
A - Grant
Stock Option (Right to Buy)
15,295
$0.00
1
$310.29M
2021-05-11
2021-05-13
RTW INVESTMENTS, LP
S - Sale
Common Stock
-725K
$40.00
-29M
1
$310.29M
2021-05-11
2021-05-13
RTW INVESTMENTS, LP
J - Other
Equity Swap (Obligation to Buy) 1)
1
1
$310.29M
2021-04-01
2021-04-01
SHAH GAURAV
CEO
F - Tax
Common Stock
-22,266
$46.00
-1.02M
3
$310.29M
2021-03-31
2021-04-01
SHAH GAURAV
CEO
M - Exercise
Stock Option (Right to Buy)
-75,880
$0.00
1
$310.29M
2021-03-31
2021-04-01
SHAH GAURAV
CEO
F - Tax
Common Stock
-94,846
$45.00
-4.27M
4
$310.29M
2021-03-31
2021-04-01
SHAH GAURAV
CEO
M - Exercise
Common Stock
75,880
$2.00
152K
1
$310.29M
2021-03-30
2021-04-01
SHAH GAURAV
CEO
F - Tax
Common Stock
-85,888
$43.00
-3.69M
4
$310.29M
2021-03-24
2021-03-29
RTW INVESTMENTS, LP
J - Other
Common Stock
-1.34M
1
$310.29M
2021-03-24
2021-03-26
PATEL KINNARI
Chief Operating Officer
M - Exercise
Common Stock
93,962
$1.00
93,962
2
$310.29M
2021-03-24
2021-03-26
PATEL KINNARI
Chief Operating Officer
M - Exercise
Stock Option (Right to Buy)
-93,962
$0.00
2
$310.29M
2020-12-31
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
72,000
$0.00
1
$310.29M
2020-12-31
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
-72,000
$0.00
1
$310.29M
2020-12-28
2021-02-16
GRANADILLO PEDRO
G - Gift
Stock Option (Right to Buy)
90,000
$0.00
3
$310.29M
2020-12-28
2021-02-16
GRANADILLO PEDRO
G - Gift
Stock Option (Right to Buy)
-90,000
$0.00
3
$310.29M
2020-12-18
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
126K
$0.00
1
$310.29M
2020-12-18
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
-126K
$0.00
1
$310.29M
2020-12-09
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
208K
$0.00
1
$310.29M
2020-12-09
2021-02-16
SHAH GAURAV
President & CEO
G - Gift
Common Stock
-208K
$0.00
1
$310.29M
2020-12-02
2021-02-16
YALAMANCHI NAVEEN
G - Gift
Common Stock
-31,250
$0.00
1
$310.29M
2021-02-04
2021-02-08
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
35,000
$0.00
1
$310.29M
2021-02-04
2021-02-08
SHAH GAURAV
President & CEO
A - Grant
Stock Option (Right to Buy)
185K
$0.00
1
$310.29M
2021-02-04
2021-02-08
PATEL KINNARI
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
120K
$0.00
1
$310.29M
2021-02-04
2021-02-08
MILITELLO JOHN
VP, Finance, Senior Controller...
D - Sale to Issuer
Stock Option (Right to Buy)
18,000
$0.00
1
$310.29M
2021-02-01
2021-02-03
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
M - Exercise
Common Stock
225K
$1.00
225K
2
$310.29M
2021-02-01
2021-02-03
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-11,428
$0.00
1
$310.29M
2020-02-10
2021-02-03
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
D - Sale to Issuer
Stock Option (Right to Buy)
-213K
$0.00
1
$310.29M
2021-01-04
2021-01-06
GARCIA-PARADA CARLOS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
125K
$0.00
1
$310.29M
2020-12-28
2020-12-30
PATEL KINNARI
Chief Operating Officer
S - Sale
Common Stock
-16,761
$57.00
-955K
2
$310.29M
2020-12-10
2020-12-14
RTW INVESTMENTS, LP
P - Purchase
Common Stock
248K
$56.00
14M
1
$310.29M
2020-10-05
2020-10-07
PATEL KINNARI
Chief Operating Officer
A - Grant
Restricted Stock Units
10,000
$0.00
1
$310.29M
2020-09-08
2020-09-10
PATEL KINNARI
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
50,000
$0.00
1
$310.29M
2020-08-03
2020-08-05
MILITELLO JOHN
VP, Finance, Senior Controller...
A - Grant
Stock Option (Right to Buy)
18,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
WONG RODERICK
A - Grant
Stock Option (Right to Buy)
27,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
BOESS CARSTEN
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
GRANADILLO PEDRO
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
MAKKER GOTHAM
A - Grant
Stock Option (Right to Buy)
32,990
$5.00
165K
3
$310.29M
2020-06-16
2020-06-18
SOUTHWELL DAVID
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-06-16
2020-06-18
YALAMANCHI NAVEEN
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-04-20
2020-04-22
BJORK ELISABETH
A - Grant
Stock Option (Right to Buy)
40,000
$0.00
1
$310.29M
2020-03-24
2020-03-26
SHAH GAURAV
President & CEO
M - Exercise
Stock Option (Right to Buy)
-90,925
$0.00
1
$310.29M
2020-03-24
2020-03-26
SHAH GAURAV
President & CEO
M - Exercise
Common Stock
90,925
$0.00
1
$310.29M
2020-03-24
2020-03-26
SHAH GAURAV
President & CEO
F - Tax
Common Stock
-32,645
$14.00
-457K
1
$310.29M
2020-03-18
2020-03-19
PATEL KINNARI
Chief Operating Officer
P - Purchase
Common Stock
1,000
$10.00
10,000
1
$310.29M
2020-02-25
2020-02-27
SHAH GAURAV
President & CEO
F - Tax
Common Stock
-6,233
$20.00
-125K
1
$310.29M
2020-02-25
2020-02-27
SHAH GAURAV
President & CEO
M - Exercise
Stock Option (Right to Buy)
-290K
$0.00
1
$310.29M
2020-02-25
2020-02-27
SHAH GAURAV
President & CEO
M - Exercise
Common Stock
290K
$0.00
1
$310.29M
2020-02-10
2020-02-10
ALAM KAMRAN
SVP - Finance & PFO
A - Grant
Stock Option (Right to Buy)
3,000
$0.00
1
$310.29M
2020-02-10
2020-02-10
MILITELLO JOHN
Senior Controller and Principa...
A - Grant
Stock Option (Right to Buy)
2,000
$0.00
1
$310.29M
2020-02-10
2020-02-10
PATEL KINNARI
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
15,000
$0.00
1
$310.29M
2020-02-10
2020-02-10
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
7,000
$0.00
1
$310.29M
2020-02-06
2020-02-10
MILITELLO JOHN
Senior Controller and Principa...
A - Grant
Stock Option (Right to Buy)
20,000
$0.00
1
$310.29M
2020-02-06
2020-02-10
PATEL KINNARI
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
150K
$0.00
1
$310.29M
2020-02-06
2020-02-10
SCHWARTZ JONATHAN DAVID
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
75,000
$0.00
1
$310.29M
2020-02-06
2020-02-10
SHAH GAURAV
President & CEO
A - Grant
Stock Option (Right to Buy)
383K
$0.00
1
$310.29M
2020-02-06
2020-02-10
ALAM KAMRAN
SVP - Finance & PFO
A - Grant
Stock Option (Right to Buy)
25,000
$0.00
1
$310.29M